Prevalence and clinical characterization of cancer patients with asymptomatic SARS-CoV-2 infection history

• We retrospectively studied the prevalence and clinical characterization of cancer patients with asymptomatic SARS-CoV-2 infection history in the only cancer hospital in Wuhan. • Serosurvey of SARS-CoV-2 among hospital visitors from two hospitals, one at the epicenter in Wuhan, and one outside the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bi, Jianping, Lin, Yongping, Zhong, Ran, Jiang, Guowu, Verma, Vivek, Shi, Hongwei, Li, Jianfu, Tong, Xianli, Li, Yanping, Hu, Desheng, Liang, Wenhua, Han, Guang, He, Jianxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375288/
https://www.ncbi.nlm.nih.gov/pubmed/32711041
http://dx.doi.org/10.1016/j.jinf.2020.07.018
_version_ 1783561852118106112
author Bi, Jianping
Lin, Yongping
Zhong, Ran
Jiang, Guowu
Verma, Vivek
Shi, Hongwei
Li, Jianfu
Tong, Xianli
Li, Yanping
Hu, Desheng
Liang, Wenhua
Han, Guang
He, Jianxing
author_facet Bi, Jianping
Lin, Yongping
Zhong, Ran
Jiang, Guowu
Verma, Vivek
Shi, Hongwei
Li, Jianfu
Tong, Xianli
Li, Yanping
Hu, Desheng
Liang, Wenhua
Han, Guang
He, Jianxing
author_sort Bi, Jianping
collection PubMed
description • We retrospectively studied the prevalence and clinical characterization of cancer patients with asymptomatic SARS-CoV-2 infection history in the only cancer hospital in Wuhan. • Serosurvey of SARS-CoV-2 among hospital visitors from two hospitals, one at the epicenter in Wuhan, and one outside the epicenter, in Guangzhou. • Cancer patients are more likely to develop asymptomatic COVID-19 infection than persons with similar exposure history. • Transmissibility of asymptomatic cases is relatively low, even in vulnerable populations such as cancer patients.
format Online
Article
Text
id pubmed-7375288
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The British Infection Association. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-73752882020-07-23 Prevalence and clinical characterization of cancer patients with asymptomatic SARS-CoV-2 infection history Bi, Jianping Lin, Yongping Zhong, Ran Jiang, Guowu Verma, Vivek Shi, Hongwei Li, Jianfu Tong, Xianli Li, Yanping Hu, Desheng Liang, Wenhua Han, Guang He, Jianxing J Infect Letter to the Editor • We retrospectively studied the prevalence and clinical characterization of cancer patients with asymptomatic SARS-CoV-2 infection history in the only cancer hospital in Wuhan. • Serosurvey of SARS-CoV-2 among hospital visitors from two hospitals, one at the epicenter in Wuhan, and one outside the epicenter, in Guangzhou. • Cancer patients are more likely to develop asymptomatic COVID-19 infection than persons with similar exposure history. • Transmissibility of asymptomatic cases is relatively low, even in vulnerable populations such as cancer patients. The British Infection Association. Published by Elsevier Ltd. 2020-12 2020-07-22 /pmc/articles/PMC7375288/ /pubmed/32711041 http://dx.doi.org/10.1016/j.jinf.2020.07.018 Text en © 2020 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Bi, Jianping
Lin, Yongping
Zhong, Ran
Jiang, Guowu
Verma, Vivek
Shi, Hongwei
Li, Jianfu
Tong, Xianli
Li, Yanping
Hu, Desheng
Liang, Wenhua
Han, Guang
He, Jianxing
Prevalence and clinical characterization of cancer patients with asymptomatic SARS-CoV-2 infection history
title Prevalence and clinical characterization of cancer patients with asymptomatic SARS-CoV-2 infection history
title_full Prevalence and clinical characterization of cancer patients with asymptomatic SARS-CoV-2 infection history
title_fullStr Prevalence and clinical characterization of cancer patients with asymptomatic SARS-CoV-2 infection history
title_full_unstemmed Prevalence and clinical characterization of cancer patients with asymptomatic SARS-CoV-2 infection history
title_short Prevalence and clinical characterization of cancer patients with asymptomatic SARS-CoV-2 infection history
title_sort prevalence and clinical characterization of cancer patients with asymptomatic sars-cov-2 infection history
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375288/
https://www.ncbi.nlm.nih.gov/pubmed/32711041
http://dx.doi.org/10.1016/j.jinf.2020.07.018
work_keys_str_mv AT bijianping prevalenceandclinicalcharacterizationofcancerpatientswithasymptomaticsarscov2infectionhistory
AT linyongping prevalenceandclinicalcharacterizationofcancerpatientswithasymptomaticsarscov2infectionhistory
AT zhongran prevalenceandclinicalcharacterizationofcancerpatientswithasymptomaticsarscov2infectionhistory
AT jiangguowu prevalenceandclinicalcharacterizationofcancerpatientswithasymptomaticsarscov2infectionhistory
AT vermavivek prevalenceandclinicalcharacterizationofcancerpatientswithasymptomaticsarscov2infectionhistory
AT shihongwei prevalenceandclinicalcharacterizationofcancerpatientswithasymptomaticsarscov2infectionhistory
AT lijianfu prevalenceandclinicalcharacterizationofcancerpatientswithasymptomaticsarscov2infectionhistory
AT tongxianli prevalenceandclinicalcharacterizationofcancerpatientswithasymptomaticsarscov2infectionhistory
AT liyanping prevalenceandclinicalcharacterizationofcancerpatientswithasymptomaticsarscov2infectionhistory
AT hudesheng prevalenceandclinicalcharacterizationofcancerpatientswithasymptomaticsarscov2infectionhistory
AT liangwenhua prevalenceandclinicalcharacterizationofcancerpatientswithasymptomaticsarscov2infectionhistory
AT hanguang prevalenceandclinicalcharacterizationofcancerpatientswithasymptomaticsarscov2infectionhistory
AT hejianxing prevalenceandclinicalcharacterizationofcancerpatientswithasymptomaticsarscov2infectionhistory

Ejemplares similares